Diacarta

Provider of in vitro diagnostic tests for precision medicine

placeRichmond, California, United States calendar_todayFounded 2011 groups100 employees language diacarta.com

Innovation

12 patent families (9 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 185 times.

YearFilings
20124
20132
20161
20173
20181
20193
20202
20212
20222
20233

Investor mix

3 investors on record; lead investors include Fortune Fountain Capital, BioVeda China Fund.

Investor typeCountShare
Venture capital133%
Bank & private debt133%
Other / undisclosed133%
Coming soon